Simulect and Exidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Simulect (basiliximab) and Exidine (chlorhexidine gluconate). Common drug interactions include kidney transplant rejection among females and kidney transplant rejection among males.

The phase IV clinical study analyzes what interactions people have when they take Simulect and Exidine. It is created by eHealthMe based on reports of 9 people who take the same drugs from the FDA, and is updated regularly.

What is Simulect?

Simulect has active ingredients of basiliximab. eHealthMe is studying from 3,861 Simulect users. Check the latest studies of Simulect.

What is Exidine?

Exidine has active ingredients of chlorhexidine gluconate. eHealthMe is studying from 17,299 Exidine users. Check the latest studies of Exidine.



On Jun, 13, 2026

9 people who take Simulect and Exidine together, and have interactions are studied.

Simulect and Exidine drug interactions.

What are the common drug interactions of Simulect and Exidine, by gender? *:

female:

  1. Kidney transplant rejection
  2. Renal tubular necrosis (death of kidney tubules)
  3. Arteritis (inflammation of the walls of arteries)
  4. Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
  5. Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery)
  6. Lymphocytic infiltration (lymphocyte deposition)
  7. Plasma cell disorder
  8. Renal tubular acidosis (medical condition that involves an accumulation of acid in the body due to a failure of the kidneys)
  9. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  10. Anal fissure

male:

  1. Kidney transplant rejection
  2. Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
  3. Bladder dilatation
  4. Blood creatinine decreased
  5. Blood lactate dehydrogenase increased
  6. Blood pressure fluctuation
  7. Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
  8. Hyperbilirubinaemia (excess of bilirubin in the blood)
  9. Leukaemoid reaction (elevated white blood cell count, or leukocytosis, that is a physiological response to stress or infection)
  10. Lung disorder (lung disease)

What are the common drug interactions of Simulect and Exidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  2. Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
  3. Leukaemoid reaction (elevated white blood cell count, or leukocytosis, that is a physiological response to stress or infection)
  4. Lung disorder (lung disease)
  5. Lung infection
  6. Pneumonia
  7. Pulmonary function test decreased

10-19:

n/a

20-29:

n/a

30-39:

  1. Kidney transplant rejection
  2. Arteritis (inflammation of the walls of arteries)
  3. Lymphocytic infiltration (lymphocyte deposition)
  4. Renal tubular necrosis (death of kidney tubules)
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  6. Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
  7. Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery)
  8. Plasma cell disorder
  9. Renal tubular acidosis (medical condition that involves an accumulation of acid in the body due to a failure of the kidneys)
  10. Anaemia (lack of blood)

40-49:

  1. Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
  2. Anal fissure
  3. Anastomotic leak
  4. Dyschezia (difficulty in defecating)
  5. Graft complication
  6. Kidney transplant rejection
  7. Procedural haemorrhage (procedural bleeding)
  8. Renal tubular necrosis (death of kidney tubules)
  9. Transplant rejection (a transplant material is not worked)
  10. Urinoma (a collection of extravasated urine)

50-59:

n/a

60+:

  1. Arteriovenous fistula
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Proteinuria (presence of protein in the urine)
  4. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  5. Vasculitis (inflammation of a blood vessel or blood vessels)
  6. Blood creatinine increased
  7. Capillaritis (inflamed capillaries under the skin)
  8. Glomerulosclerosis (a hardening of the glomerulus in the kidney)
  9. Hypertension (high blood pressure)
  10. Kidney transplant rejection

* Approximation only. Some reports may have incomplete information.

Do you take Simulect and Exidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Simulect and Exidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Simulect:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Exidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Simulect and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Exidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on basiliximab and chlorhexidine gluconate (the active ingredients of Simulect and Exidine, respectively), and Simulect and Exidine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: